Back to top

Image: Bigstock featured highlights United Therapeutics, StoneCo, Reinsurance Group of America and United Airlines

Read MoreHide Full Article

For Immediate Release

Chicago, IL – December 8, 2022 – Stocks in this week’s article are United Therapeutics Corp. (UTHR - Free Report) , StoneCo Ltd. (STNE - Free Report) , Reinsurance Group of America, Inc. (RGA - Free Report) and United Airlines Holdings, Inc. (UAL - Free Report) .

4 Stocks with Upgrade Broker Ratings for Attractive Returns

While recent economic data point to some effectiveness of the Federal Reserve’s ultra-aggressive monetary tightening, we are still not out of the woods. The central bank is expected to keep raising interest rates until inflation comes down reasonably. This has made investors wary as higher rates will lead to a recession in the next six-nine months.

The pessimistic investor sentiments are leading to huge market volatility, making it difficult for individual investors to pick stocks independently and generate solid returns. At this stage, one way to choose the right stocks in the current situation is to follow rating upgrades by brokers. In this regard, stocks like United Therapeutics Corp., StoneCo Ltd., Reinsurance Group of America, Inc. and United Airlines Holdings, Inc. are worth considering.

As brokers directly communicate with the top management, they have a deeper understanding into what is happening in a particular company. They meticulously assess companies’ publicly available documents and even attend conference calls.

Brokers have a more understanding of the overall sector and industry. They place company fundamentals against the current economic backdrop to determine how a particular stock will fare as an investment.

So, when brokers upgrade a stock, you can rely on their judgment. But solely depending on broker upgrades is not a good way to build your investment portfolio. Several other factors should be taken into consideration to ensure steady returns.

Here are four stocks that qualified for the screening:

Silver Spring, MD-based United Therapeutics markets four medicines in the United States to treat pulmonary arterial hypertension. UTHR is also engaged in research and development efforts to increase the supply of transplantable organs and tissues through regenerative medicine and organ manufacturing.

United Therapeutics’ 2022 earnings are projected to jump 65.1%. The company, carrying a Zacks Rank #2 at present, has witnessed an 8.3% upward revision in broker ratings over the past four weeks.

Cayman Islands-based StoneCo provides financial technology solutions to merchants and integrated partners to conduct electronic commerce across in-store, online and mobile channels in Brazil. STNE distributes its solutions to digital merchants through sales and technical personnel and software vendors.

The company’s earnings for 2022 are expected to surge 191.7%. StoneCo, currently carries a Zacks Rank #2, has witnessed an 11.1% upward revision in broker ratings over the past four weeks.

Headquartered in Chesterfield, MO, Reinsurance Group of America is a leading global provider of traditional life and health reinsurance and financial solutions. RGA reports through four geographic segments: the United States and Latin America, Canada, Europe, the Middle East and Africa, and Asia Pacific.

Reinsurance Group of America’s 2022 earnings are projected to surge 1224.8%. The company, carrying a Zacks Rank #2 at present, has witnessed a 14.3% upward revision in broker ratings over the past four weeks.

United Airlines, based in Chicago, transports people and cargo not only throughout North America but also to destinations in Asia, Europe, the Middle East and Latin America. UAL is part of four passenger joint business arrangements

United Airlines’ 2022 earnings are projected to jump 114.3%. The company, carrying a Zacks Rank #2 at present, has witnessed a 6.3% upward revision in broker ratings over the past four weeks.

The Research Wizard is a great place to begin. It's easy to use. Everything is in plain language. And it's very intuitive. Start your Research Wizard trial today. And the next time you read an economic report, open up the Research Wizard, plug your finds in, and see what gems come out.

Click here to sign up for a free trial to the Research Wizard today.

For the rest of this Screen of the Week article please visit at:

Disclosure: Officers, directors and/or employees of Zacks Investment Research may own or have sold short securities and/or hold long and/or short positions in options that are mentioned in this material. An affiliated investment advisory firm may own or have sold short securities and/or hold long and/or short positions in options that are mentioned in this material.

About Screen of the Week created the first and best screening system on the web earning the distinction as the "#1 site for screening stocks" by Money Magazine.  But powerful screening tools is just the start. That is why Zacks created the Screen of the Week to highlight profitable stock picking strategies that investors can actively use.

Strong Stocks that Should Be in the News

Many are little publicized and fly under the Wall Street radar. They're virtually unknown to the general public. Yet today's 220 Zacks Rank #1 "Strong Buys" were generated by the stock-picking system that has more than doubled the market from 1988 through 2016. Its average gain has been a stellar +25% per year. See these high-potential stocks free >>.

Follow us on Twitter:

Join us on Facebook:

Zacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates.

Contact: Jim Giaquinto


Phone: 312-265-9268


Visit: provides investment resources and informs you of these resources, which you may choose to use in making your own investment decisions. Zacks is providing information on this resource to you subject to the Zacks "Terms and Conditions of Service" disclaimer.

Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit for information about the performance numbers displayed in this press release.

Published in